Pain Management Services M&A

The U.S. pain management market to hit $53.6 billion by 2030 amid 24.3% chronic pain  prevalence and $725 billion economic burden.

• The pain management industry currently includes 35,830 specialized physicians, and the sector is projected to grow from $44.5B in 2024 to reach $53.6B by 2030 (a steady CAGR of 3.1%).1
• Between 2019 and 2023, the prevalence of chronic pain rose from 20.4% to 24.3%, reflecting a broader rise in chronic conditions. Spending on pain management is rising as chronic pain prevalence increases and new treatment technologies, such as neuromodulation devices, become available.2
• Chronic pain management imposes a national economic burden exceeding $725 billion annually, excluding additional costs from lost productivity and missed workdays.3
• Demand for interventional pain management services is experiencing steady growth, driven by the aging population, increasing prevalence of chronic pain conditions and the rising demand for minimally invasive, non-opioid and non- pharmacologic treatments.
• These procedures, such as epidural steroid injections, nerve blocks, radiofrequency ablation, and spinal cord stimulation, offer targeted relief, often reducing the need for major surgery and long-term opioid use.